Aitalina Sukhomyasova

Aitalina Sukhomyasova

Auto-generated profile, based on publicly available information

Aitalina Sukhomyasova

M.K. Ammosov North-Eastern Federal University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2020 in Genes
Verified
Journal Article
Open access
PDF file
AZAlexei Zarubin
Alexei Zarubin
VSVadim A. Stepanov
Vadim A. Stepanov
AMAnton Markov
Anton Markov
Nikita KolesnikovNikita Kolesnikov
Nikita Kolesnikov
AMAndrey Marusin
Andrey Marusin
VKVladimir Kharkov
Vladimir Kharkov
The human serine protease serine 2 TMPRSS2 is involved in the priming of proteins of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and represents a possible target for COVID-19 therapy. The TMPRSS2 gene may be co-expressed with SARS-CoV-2 cell receptor genes angiotensin-converting enzyme 2 (ACE2) and Basigin (BSG), but only TMPRSS2 demonstrates tissue-specific expression in alveolar cells according to single-cell RNA sequencing data. Our analysis of the structural variability of the TMPRSS2 gene based on genome-wide data from 76 human populations demonstrates that a functionally significant missense mutation in exon 6/7 in the TMPRSS2 gene is found in many human populations at relatively high frequencies, with region-specific distribution patterns. The frequency of the missense mutation encoded by rs12329760, which has previously been found to be associated with prostate cancer, ranged between 10% and 63% and was significantly higher in populations of Asian origin compared with European populations. In addition to single-nucleotide polymorphisms, two copy number variants were detected in the TMPRSS2 gene. A number of microRNAs have been predicted to regulate TMPRSS2 and BSG expression levels, but none of them is enriched in lung or respiratory tract cells. Several well-studied drugs can downregulate the expression of TMPRSS2 in human cells, including acetaminophen (paracetamol) and curcumin. Thus, the interactions of TMPRSS2 with SARS-CoV-2, together with its structural variability, gene–gene interactions, expression regulation profiles, and pharmacogenomic properties, characterize this gene as a potential target for COVID-19 therapy.

Verified
Journal Article
Open access
PDF file
FVFilipp Vasilev
Filipp Vasilev
ASAitalina Sukhomyasova
Aitalina Sukhomyasova
TOTakanobu Otomo
Takanobu Otomo
Previously, we reported a novel disease of impaired glycosaminoglycans (GAGs) metabolism without deficiency of known lysosomal enzymes—mucopolysaccharidosis-plus syndrome (MPSPS). MPSPS, whose pathophysiology is not elucidated, is an autosomal recessive multisystem disorder caused by a specific mutation p.R498W in the VPS33A gene. VPS33A functions in endocytic and autophagic pathways, but p.R498W mutation did not affect both of these pathways in the patient’s skin fibroblast. Nineteen patients with MPSPS have been identified: seventeen patients were found among the Yakut population (Russia) and two patients from Turkey. Clinical features of MPSPS patients are similar to conventional mucopolysaccharidoses (MPS). In addition to typical symptoms for conventional MPS, MPSPS patients developed other features such as congenital heart defects, renal and hematopoietic disorders. Diagnosis generally requires evidence of clinical picture similar to MPS and molecular genetic testing. Disease is very severe, prognosis is unfavorable and most of patients died at age of 10–20 months. Currently there is no specific therapy for this disease and clinical management is limited to supportive and symptomatic treatment.

1 January 2017 in Procedia Engineering
Verified
Journal Article
Open access
Sergey V PaninSergey V Panin
Sergey V Panin
Pavlo MaruschakPavlo Maruschak
Pavlo Maruschak
IVI.V. Vlasov
I.V. Vlasov
ASA.S. Syromyatnikova
A.S. Syromyatnikova
ABA.M. Bolshakov
A.M. Bolshakov
BOB.B. Ovechkin
B.B. Ovechkin

Verified
Journal Article
Open access
PDF file
VSViktoriia Sofronova
Viktoriia Sofronova
RIRina Iwata
Rina Iwata
TMTakuya Moriya
Takuya Moriya
KLKiunniai Loskutova
Kiunniai Loskutova
EGElizaveta Gurinova
Elizaveta Gurinova
TOTakanobu Otomo
Takanobu Otomo
Mucopolysaccharidoses (MPS) are rare lysosomal storage disorders (LSD) characterized by the excessive accumulation of glycosaminoglycans (GAG). Conventional MPS, caused by inborn deficiencies of lysosomal enzymes involved in GAG degradation, display various multisystemic symptoms—including progressive neurological complications, ophthalmological disorders, hearing loss, gastrointestinal and hepatobiliary issues, cardiorespiratory problems, bone and joint abnormalities, dwarfism, and coarse facial features. Mucopolysaccharidosis-Plus Syndrome (MPSPS), an autosomal recessive disease caused by a mutation in the endo-lysosomal tethering protein VPS33A, shows additional renal and hematopoietic abnormalities (“Plus symptoms”) uncommon in conventional MPS. Here, we analyze data from biochemical, histological, and physical examinations—particularly of blood counts and kidney function—to further characterize the clinical phenotype of MPSPS. A series of blood tests indicate hematopoietic symptoms including progressive anemia and thrombocytopenia, which correlate with histological observations of hypoplastic bone marrow. High urinary excretion of protein (caused by impairments in renal filtration), hypoalbuminemia, and elevated levels of creatinine, cholesterol, and uric acid indicate renal dysfunction. Histological analyses of MPSPS kidneys similarly suggest the extensive destruction of glomerular structures by foamy podocytes. Height and weight did not significantly deviate from the average, but in some cases, growth began to decline at around six months or one year of age.

1 April 2017 in Physical Mesomechanics
Verified
Journal Article
Closed access
PDF file
VPV. E. Panin
V. E. Panin
LDL. S. Derevyagina
L. S. Derevyagina
MLM. P. Lebedev
M. P. Lebedev
ASA. S. Syromyatnikova
A. S. Syromyatnikova
NSN. S. Surikova
N. S. Surikova
BOB. B. Ovechkin
B. B. Ovechkin
The paper considers the physics of cold brittleness of structural bcc steels and methods of reducing the ductile-brittle fracture temperature. A complex study was performed to examine the degradation of structural phase state of pipe steel 09Mn2Si from the main gas pipeline of Yakutia after long-term (over 3 0 years) operation. Important regularities of degradation of pearlite colonies with carbide precipitation on ferrite grain boundaries were revealed. This phenomenon is associated with brittle fracture of gas pipelines. It is shown that the low-temperature kinetic processes in main pipelines which define the degradation of their structure and properties are related to interstitial athermal structural states in the zones of local crystal structure curvature. This is a fundamentally new, as yet unknown, mechanism. Pipe steels in warm rolling acquire a longitudinal textured band structure with alternating bands of initial ferrite grains and bands of fine grains with carbide precipitates formed during lamellar pearlite degradation. This type of structure allows for a shift of ductile-brittle transition temperature down to -80°C and ductility δ = 22% at this temperature. The production of high-curvature vortex structure in pipe steel surface layers results in a 3.5-fold increase in their service life.

20 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
AZAlexei Zarubin
Alexei Zarubin
VSVadim A. Stepanov
Vadim A. Stepanov
AMAnton Markov
Anton Markov
Nikita KolesnikovNikita Kolesnikov
Nikita Kolesnikov
AMAndrey Marusin
Andrey Marusin
VKVladimir Kharkov
Vladimir Kharkov
The human serine protease TMPRSS2 gene is involved in the priming of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins being one of the possible targets for COVID-19 therapy. TMPRSS2 gene is possibly co-expressed with SARS-CoV-2 cell receptor genes ACE2 and BSG, but only TMPRSS2 demonstrates tissue-specific expression in alveolar cells according to single cell RNA sequencing data. Our analysis of the structural variability of the TMPRSS2 gene based on genome-wide data of 76 human populations demonstrates that functionally significant missense mutation in exon 6/7 in TMPRSS2 gene, was found in many human populations in relatively high frequency, featuring region-specific distribution patterns. The frequency of the missense mutation encoded by the rs12329760, which previously was found to be associated with prostate cancer, is ranged between 10% and 63% being significantly higher in populations of Asian origin compared to European populations. In addition to SNPs, two copy numbers variants (CNV) were detected in the TMPRSS2 gene. Number of microRNAs have been predicted to regulate TMPRSS2 and BSG expression levels, but none of them is enriched in lung or respiratory tract cells. Several well studied drugs can downregulate the expression of TMPRSS2 in human cells, including Acetaminophen (Paracetamol) and Curcumin. Thus TMPRSS2 interaction with the SARS-CoV-2, its structural variability, gene-gene interactions, and expression regulation profiles, and pharmacogenomics properties characterize this gene as a potential target for COVID-19 therapy.